## Abstract ZEB1 and SNAIL repress __CDH1__ and induce epithelial–mesenchymal transition (EMT). However, SNAIL and ZEB1 also activate or regulate other target genes in different ways. For instance, vitamin D receptor (VDR), which activates __CDH1__ expression upon ligand binding, is repressed by SN
Butyrate and vitamin D3 induce transcriptional attenuation at the cyclin D1 locus in colonic carcinoma cells
✍ Scribed by Sandra Maier; M. Cecilia Daroqui; Stefan Scherer; Stefan Roepcke; Anna Velcich; Shailesh M. Shenoy; Robert H. Singer; Leonard H. Augenlicht
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 249 KB
- Volume
- 218
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In stimulating maturation of colonic carcinoma cells, the short chain fatty acid butyrate, and 1α,25‐dihydroxyvitamin D~3~, were shown to attenuate transcription of the cyclin D1 gene, giving rise to truncated transcripts of this locus. Moreover, a sequence which is highly conserved in the human, mouse, rat, and dog genome was found in the 4 kb long intron 3 of the human cyclin D1 gene, and is capable of forming a hairpin structure similar to that of microRNA precursors. The expression of this sequence is also decreased by the attenuation. Thus, the transcriptional attenuation at the cyclin D1 locus not only down‐regulates the expression of this key gene in mucosal cell maturation and tumorigenesis, but may also abrogate the generation of a molecule that encompasses this conserved sequence in cyclin D1 intron 3. J. Cell. Physiol. 218: 638–642, 2009. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Interaction between c‐fos and 1,25(OH)~2~ vitamin D~3~ (VD) on the type I collagen synthesis was studied. VD inhibited collagen synthesis and type I collagen mRNA expression in MC3T3‐E1 osteoblastic cells. In contrast, VD reversed the inhibition of collagen synthesis and mRNA expression
## Abstract The anti‐neoplastic effects of 1,25‐dihydroxyvitamin D~3~ (1,25D) are well documented in numerous tumor cell systems and animal models of cancer. However, despite this pre‐clinical success, the clinical use of 1,25D is currently impeded by the dose‐limiting hypercalcemia, and the risk o